The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases · 1987 · 49.9K citations

Public Health, Biostatistics, Clinical Classification Systems +15

Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go et al. · PubMed · 2015 · 8.3K citations

Medicine, Cardiology, Internal Medicine +10

Heart Disease and Stroke Statistics—2015 Update

Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go et al. · Circulation · 2014 · 5.8K citations

Medicine, Cardiology, Disease Surveillance +8

Improved survival in multiple myeloma and the impact of novel therapies

Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri et al. · Blood · 2007 · 2.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Laura F. Hutchins, Joseph M. Unger, John J. Crowley et al. · New England Journal of Medicine · 1999 · 2.2K citations

Medicine, Geriatric Medicine, Oncology +13